<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <award-group id="award001">
  <funding-source>
   <institution>HIVERA: Harmonizing Integrating Vitalizing European Research on HIV/Aids</institution>
  </funding-source>
  <award-id>249697</award-id>
  <principal-award-recipient>
   <name>
    <surname>Abecasis</surname>
    <given-names>Ana</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award002">
  <funding-source>
   <institution>L’Oréal Portugal, Comissão Nacional da Unesco</institution>
  </funding-source>
  <principal-award-recipient>
   <name>
    <surname>Abecasis</surname>
    <given-names>Ana</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award003">
  <funding-source>
   <institution>FCT for funds to GHTM</institution>
  </funding-source>
  <award-id>UID/Multi/04413/2013</award-id>
 </award-group>
 <award-group id="award004">
  <funding-source>
   <institution>Fundação para a Ciência e Tecnologia</institution>
  </funding-source>
  <award-id>PTDC/DTP-EPI/7066/2014</award-id>
  <principal-award-recipient>
   <name>
    <surname>Abecasis</surname>
    <given-names>Ana</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award005">
  <funding-source>
   <institution>Gilead Génese HIVLatePresenters</institution>
  </funding-source>
  <award-id>HIVLatePresenters</award-id>
  <principal-award-recipient>
   <name>
    <surname>Abecasis</surname>
    <given-names>Ana</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award006">
  <funding-source>
   <institution>National Nature Science Foundation of China</institution>
  </funding-source>
  <award-id>31571368</award-id>
  <principal-award-recipient>
   <name>
    <surname>Li</surname>
    <given-names>Guangdi</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award007">
  <funding-source>
   <institution>Innovation-driven Project of Central South University</institution>
  </funding-source>
  <award-id>2016CX031</award-id>
  <principal-award-recipient>
   <name>
    <surname>Li</surname>
    <given-names>Guangdi</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award008">
  <funding-source>
   <institution>Fonds voor Wetenschappelijk Onderzoek – Flanders (FWO)</institution>
  </funding-source>
  <award-id>G.0692.14</award-id>
  <principal-award-recipient>
   <name>
    <surname>Theys</surname>
    <given-names>Kristof</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award009">
  <funding-source>
   <institution>Fonds voor Wetenschappelijk Onderzoek – Flanders (FWO)</institution>
  </funding-source>
  <award-id>G.0611.09N</award-id>
  <principal-award-recipient>
   <name>
    <surname>Theys</surname>
    <given-names>Kristof</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award010">
  <funding-source>
   <institution>European Union’s Horizon 2020 research and innovation programme</institution>
  </funding-source>
  <award-id>634650</award-id>
  <principal-award-recipient>
   <name>
    <surname>Theys</surname>
    <given-names>Kristof</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award011">
  <funding-source>
   <institution>Hercules Foundation and the Flemish Government</institution>
  </funding-source>
  <award-id>KAN2012 1.5.249.12</award-id>
  <principal-award-recipient>
   <name>
    <surname>Theys</surname>
    <given-names>Kristof</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <funding-statement>This study was supported by European Funds through grant ‘Bio-Molecular and Epidemiological Surveillance of HIV Transmitted Drug Resistance, Hepatitis Co-Infections and Ongoing Transmission Patterns in Europe - BEST HOPE - (project funded through HIVERA: Harmonizing Integrating Vitalizing European Research on HIV/Aids, grant 249697)’ to ABA; by L’'Oréal Portugal Medals of Honor for Women in Science 2012 (financed through L’'Oréal Portugal, Comissão Nacional da Unesco and Fundação para a Ciência e Tecnologia (FCT - 
  <ext-link ext-link-type="uri" xlink:href="http://www.fct.pt" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.fct.pt</ext-link>)) to ABA; by FCT for funds to GHTM-UID/Multi/04413/2013; by the MigrantHIV project (financed by FCT: PTDC/DTP-EPI/7066/2014 to ABA; by Gilead Génese HIVLatePresenters to ABA; by the National Nature Science Foundation of China (31571368) to GL; by the Innovation-driven Project of Central South University (2016CX031) to GL; by the Fonds voor Wetenschappelijk Onderzoek – Flanders (FWO) grant G.0692.14, and G.0611.09N to KT; by the VIROGENESIS project that receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634650 to KT. The computational resources and services used in this work were provided by the Hercules Foundation and the Flemish Government – department EWI-FWO Krediet aan Navorsers (Theys, KAN2012 1.5.249.12.) to KT. KT is supported by a postdoctoral grant from FWO. BV is supported by a postdoctoral grant of the FWO (Fonds Wetenschappelijk Onderzoek – Vlaanderen). L’'Oréal Portugal, Comissão Nacional da Unesco and Gilead Génese HIVLatePresenters had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
 </funding-statement>
</funding-group>
